Pathology is at the heart of medical diagnosis but it is largely manual. This causes delays, errors in detection, and interobserver variability. Pathologists are also in short supply.
Morphle is solving two core issues hindering digitization of pathology. It builds scanners that can work with lower quality slide images, at a price ~1/10th of what the current market leaders charge. It is also building an AI studio on top of these machines to enable automated diagnosis.
Rohit Hiwale, CEO